96 related articles for article (PubMed ID: 9388658)
1. Correlated mutations and subtype specificity in the adrenergic receptor.
Gouldson PR; Bywater RP; Reynolds CA
Biochem Soc Trans; 1997 Aug; 25(3):434S. PubMed ID: 9388658
[No Abstract] [Full Text] [Related]
2. Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6.
Ballesteros JA; Jensen AD; Liapakis G; Rasmussen SG; Shi L; Gether U; Javitch JA
J Biol Chem; 2001 Aug; 276(31):29171-7. PubMed ID: 11375997
[TBL] [Abstract][Full Text] [Related]
3. Identification of critical determinants of alpha 1-adrenergic receptor subtype selective agonist binding.
Hwa J; Graham RM; Perez DM
J Biol Chem; 1995 Sep; 270(39):23189-95. PubMed ID: 7559466
[TBL] [Abstract][Full Text] [Related]
4. Mutation of a single TMVI residue, Phe(282), in the beta(2)-adrenergic receptor results in structurally distinct activated receptor conformations.
Chen S; Lin F; Xu M; Riek RP; Novotny J; Graham RM
Biochemistry; 2002 May; 41(19):6045-53. PubMed ID: 11993999
[TBL] [Abstract][Full Text] [Related]
5. In vivo mutation of the alpha 2A-adrenergic receptor by homologous recombination reveals the role of this receptor subtype in multiple physiological processes.
MacMillan LB; Lakhlani PP; Hein L; Piascik M; Guo TZ; Lovinger D; Maze M; Limbird LE
Adv Pharmacol; 1998; 42():493-6. PubMed ID: 9327947
[No Abstract] [Full Text] [Related]
6. The conserved aspartate residue in the third putative transmembrane domain of the delta-opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site.
Befort K; Tabbara L; Bausch S; Chavkin C; Evans C; Kieffer B
Mol Pharmacol; 1996 Feb; 49(2):216-23. PubMed ID: 8632752
[TBL] [Abstract][Full Text] [Related]
7. Site-directed mutagenesis of the human beta3-adrenoceptor--transmembrane residues involved in ligand binding and signal transduction.
Gros J; Manning BS; Pietri-Rouxel F; Guillaume JL; Drumare MF; Strosberg AD
Eur J Biochem; 1998 Feb; 251(3):590-6. PubMed ID: 9490030
[TBL] [Abstract][Full Text] [Related]
8. Aspartate mutation distinguishes ETA but not ETB receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors.
Rose PM; Krystek SR; Patel PS; Liu EC; Lynch JS; Lach DA; Fisher SM; Webb ML
FEBS Lett; 1995 Mar; 361(2-3):243-9. PubMed ID: 7698331
[TBL] [Abstract][Full Text] [Related]
9. Site-directed mutagenesis analysis of the role of the M5S5 sector of the sarcoplasmic reticulum Ca(2+)-ATPase.
Andersen JP; Sørensen T; Vilsen B
Ann N Y Acad Sci; 1997 Nov; 834():333-8. PubMed ID: 9432910
[No Abstract] [Full Text] [Related]
10. Molecular mechanisms of ligand binding and activation in alpha 1-adrenergic receptors.
Perez DM; Hwa J; Zhao MM; Porter J
Adv Pharmacol; 1998; 42():398-403. PubMed ID: 9327924
[No Abstract] [Full Text] [Related]
11. Mapping the binding-site crevice of the D2 receptor.
Javitch JA
Adv Pharmacol; 1998; 42():412-5. PubMed ID: 9327927
[No Abstract] [Full Text] [Related]
12. Dominant-negative activity of an alpha(1B)-adrenergic receptor signal-inactivating point mutation.
Chen S; Lin F; Xu M; Hwa J; Graham RM
EMBO J; 2000 Aug; 19(16):4265-71. PubMed ID: 10944109
[TBL] [Abstract][Full Text] [Related]
13. Residues in transmembrane regions III and VI contribute to the 5-ht6 receptor ligand binding site.
Boess FG; Monsma FJ; Bourson A; Zwingelstein C; Sleight AJ
Ann N Y Acad Sci; 1998 Dec; 861():242-3. PubMed ID: 9928266
[No Abstract] [Full Text] [Related]
14. Altered ligand dissociation rates in thyrotropin-releasing hormone receptors mutated in glutamine 105 of transmembrane helix III.
del Camino D; Barros F; Pardo LA; de la Peña P
Biochemistry; 1997 Mar; 36(11):3308-18. PubMed ID: 9116009
[TBL] [Abstract][Full Text] [Related]
15. An aspartate in the second extracellular loop of the α(1B) adrenoceptor regulates agonist binding.
Campbell AP; MacDougall IJ; Griffith R; Finch AM
Eur J Pharmacol; 2014 Jun; 733():90-6. PubMed ID: 24690260
[TBL] [Abstract][Full Text] [Related]
16. Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production.
Du K; Nicole P; Couvineau A; Laburthe M
Biochem Biophys Res Commun; 1997 Jan; 230(2):289-92. PubMed ID: 9016768
[TBL] [Abstract][Full Text] [Related]
17. Importance of Thr214 in the conserved TGES sequence of the Na+,K+-ATPase for vanadate binding and hydrolysis of E2P.
Toustrup-Jensen M; Vilsen B
Ann N Y Acad Sci; 2003 Apr; 986():267-9. PubMed ID: 12763817
[No Abstract] [Full Text] [Related]
18. A dileucine motif in the C terminus of the beta2-adrenergic receptor is involved in receptor internalization.
Gabilondo AM; Hegler J; Krasel C; Boivin-Jahns V; Hein L; Lohse MJ
Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12285-90. PubMed ID: 9356441
[TBL] [Abstract][Full Text] [Related]
19. Structure-specificity features of HSV-1 thymidine kinases.
Evans JS; Lock KP; Levine BA; Champness JN; Sanderson MR; Summers WC; Buchan A
Biochem Soc Trans; 1997 Nov; 25(4):S621. PubMed ID: 9450049
[No Abstract] [Full Text] [Related]
20. [Adrenergic receptor and alpha 2 agonist--2: Structure-function relationship of adrenoceptors].
Mizobe T
Masui; 1997 Jun; 46(6):770-6. PubMed ID: 9223879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
